NCT04472650View on ClinicalTrials.gov

Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

November 9, 2020

Study Completion Date

November 9, 2020

Conditions
Tumor
Interventions
DRUG

Sitravatinib

Administered orally as a free base capsule

DRUG

Sitravatinib

Administered orally as a malate salt capsule

Trial Locations (1)

6009

Linear Clinical Research, Nedlands

Sponsors

Lead Sponsor

BeiGene
All Listed Sponsors
lead

BeiGene

INDUSTRY

NCT04472650 - Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults | Biotech Hunter | Biotech Hunter